Literature DB >> 23730637

Occurrence of the CTX-M, SHV and the TEM Genes Among the Extended Spectrum β-Lactamase Producing Isolates of Enterobacteriaceae in a Tertiary Care Hospital of North India.

Maninder Kaur1, Aruna Aggarwal.   

Abstract

PURPOSE: The present study was carried out to assess the prevalence of the Extended Spectrum Beta Lactamases (ESBLs) and to characterize the ESBL types which were prevalent in our hospital. MATERIAL
METHODS: Five hundred gram negative isolates which belonged to the family, Enterobacteriaceae, which were isolated during the study period of 2009 to 2011, were investigated for ESBL production. Clinical isolates from urine (344), pus (109), blood (15), IV/ central line tip (10), sputum (12) and body fluid (10) specimens were processed. The organisms which were identified, included E.coli (351), Klebsiella pneumoniae (74), Klebsiella oxytoca (21), Proteus mirabilis (15), Proteus vulgaris (9), Enterobacter spp (15) and Citrobacterspp (15). Antimicrobial susceptibility testing was done. The ESBL detection was carried out for all the isolates by the CLSI confirmatory method. The MIC of ceftazidime and ceftazidime plus clavulanic acid was determined by the E-test. Molecular typing of the ESBLs was performed by multiplex PCR among 93 ESBL isolates.
RESULTS: 45.8% isolates were found to be ESBL producers by the CLSI confirmatory method and they were confirmed by the E-test ESBL strips. A majority of E.coli in the study possessed the CTX-M genes (59.32%). Among the Klebsiella isolates, a majority were co producers of the ESBL genes; either 2 or all the 3 genes co-existed together.
CONCLUSION: An indiscriminate use of the higher antibiotics should be restricted as far as possible. The infection control programmes should be monitored continuously in hospitals, to contain these ESBL producers. We are reporting the presence of all types of ESBL genes among the Enterobacteriaceae isolates from our hospital setting.

Entities:  

Keywords:  Enterobacteriaceae; Extended spectrum beta lactamase

Year:  2013        PMID: 23730637      PMCID: PMC3644435          DOI: 10.7860/JCDR/2013/5081.2872

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

Authors:  L S Tzouvelekis; E Tzelepi; P T Tassios; N J Legakis
Journal:  Int J Antimicrob Agents       Date:  2000-03       Impact factor: 5.283

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Real-time polymerase chain reaction for rapid detection of genes encoding SHV extended-spectrum β-lactamases.

Authors:  M S Alfaresi; A A Elkoush
Journal:  Indian J Med Microbiol       Date:  2010 Oct-Dec       Impact factor: 0.985

4.  Sequence analysis of bla CTX-M-28 , an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India.

Authors:  Jemima Kingsley; Susan Verghese
Journal:  Indian J Pathol Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.740

5.  Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India.

Authors:  J B Hansotia; V Agarwal; A A Pathak; A M Saoji
Journal:  Indian J Med Res       Date:  1997-04       Impact factor: 2.375

6.  Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility.

Authors:  A Manoharan; K Premalatha; S Chatterjee; D Mathai
Journal:  Indian J Med Microbiol       Date:  2011 Apr-Jun       Impact factor: 0.985

7.  Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.

Authors:  Purva Mathur; Arti Kapil; Bimal Das; Benu Dhawan
Journal:  Indian J Med Res       Date:  2002-04       Impact factor: 2.375

8.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases.

Authors:  David L Paterson; Kristine M Hujer; Andrea M Hujer; Bethany Yeiser; Michael D Bonomo; Louis B Rice; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Detection of Enterobacteriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in south India.

Authors:  S Baby Padmini; B Appala Raju; K R Mani
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

  10 in total
  14 in total

1.  Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital.

Authors:  Balaram Khamari; Manmath Lama; Chanakya Pachi Pulusu; Amarendra Pratap Biswal; Sai Manoz Lingamallu; Bhargava Sai Mukkirla; Amit Kumar Sahoo; Harioum Sambhu Narayan Dash; Rewa Sharda; Prakash Kumar; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

2.  Genome sequencing and comparative analysis of an NDM-1-producing Klebsiella pneumoniae ST15 isolated from a refugee patient.

Authors:  Tamara Salloum; Harout Arabaghian; Sahar Alousi; Edmond Abboud; Sima Tokajian
Journal:  Pathog Glob Health       Date:  2017-04-11       Impact factor: 2.894

3.  Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure.

Authors:  Thorsten Schauss; Stefanie P Glaeser; Alexandra Gütschow; Wolfgang Dott; Peter Kämpfer
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

4.  Emerging Perils of Extended Spectrum β-Lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal.

Authors:  Narayan Prasad Parajuli; Pooja Maharjan; Govardhan Joshi; Puspa Raj Khanal
Journal:  Biomed Res Int       Date:  2016-12-29       Impact factor: 3.411

5.  Characterization of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients.

Authors:  Mehrdad Halaji; Shahrzad Shahidi; Abdolamir Atapour; Behrooz Ataei; Awat Feizi; Seyed Asghar Havaei
Journal:  Infect Drug Resist       Date:  2020-05-15       Impact factor: 4.003

6.  Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka.

Authors:  Sridhar Pn Rao; Prasad Subba Rama; Vishwanath Gurushanthappa; Radhakrishna Manipura; Krishna Srinivasan
Journal:  J Lab Physicians       Date:  2014-01

7.  Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran.

Authors:  A Peymani; T Naserpour-Farivar; E Zare; K H Azarhoosh
Journal:  J Prev Med Hyg       Date:  2017-06

8.  Virulence determinant and extended spectrum beta-lactamase production in Klebsiella pneumoniae isolated from a tertiary care hospital, South India.

Authors:  Lathamani Kotekani; Subbannayya Kotigadde
Journal:  J Lab Physicians       Date:  2018 Apr-Jun

9.  Phenotypic and genotypic characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae from blood culture specimens: A study from North India.

Authors:  Varsha Gupta; Ritu Garg; Karthikeyan Kumaraswamy; Priya Datta; Gursimran Kaur Mohi; Jagdish Chander
Journal:  J Lab Physicians       Date:  2018 Apr-Jun

10.  Bioassay Guided Isolation and Docking Studies of a Potential β-Lactamase Inhibitor from Clutia myricoides.

Authors:  Mahmoud A Elfaky; Ali M El-Halawany; Abdulrahman E Koshak; Khalid Z Alshali; Moustafa E El-Araby; Maan T Khayat; Hossam M Abdallah
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.